XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Equity-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Equity Compensation Expense

Equity compensation expense is included in operating expenses and in selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of comprehensive income (loss) as follows:  

 

 

 

For the Three Months Ended

June 30,

 

 

For the Six Months Ended

June 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

 

 

(In thousands)

 

Equity compensation expense included in operating expenses

 

$

676

 

 

$

2,667

 

 

$

2,033

 

 

$

4,230

 

Equity compensation expense included in selling, general and administrative expenses

 

 

3,408

 

 

 

3,225

 

 

 

5,249

 

 

 

9,207

 

Total equity compensation expense

 

$

4,084

 

 

$

5,892

 

 

$

7,282

 

 

$

13,437

 

Schedule of Time-Vesting and Performance Vesting Restricted Share Awards

The activity related to the Company’s time-vesting and performance-vesting awards during the six months ended June 30, 2019 is as follows: 

 

 

 

 

 

 

 

 

 

 

Performance-Vesting Restricted Awards

 

 

 

Time-Vesting

Restricted Awards

 

 

Bonus Performance

Restricted Awards

 

 

Long-Term

Incentive

Performance

Restricted Awards

 

 

 

Shares/Units

 

 

Weighted

Average

Grant Date

Fair Value

per Award

 

 

Units

 

 

Weighted

Average

Grant Date

Fair Value

per Award

 

 

Shares/Units

 

 

Weighted

Average

Grant Date

Fair Value

per Award

 

Outstanding at December 31, 2018

 

 

901,704

 

 

$

17.34

 

 

 

560,710

 

 

$

15.06

 

 

 

1,155,486

 

 

$

15.82

 

Granted

 

 

72,078

 

 

$

27.02

 

 

 

225,080

 

 

$

25.70

 

 

 

1,233,742

 

 

$

25.70

 

Vested

 

 

(144,340

)

 

$

18.75

 

 

 

(321,715

)

 

$

15.05

 

 

 

(32,233

)

 

$

15.36

 

Forfeited

 

 

(155,723

)

 

$

15.15

 

 

 

(259,814

)

 

$

15.93

 

 

 

(413,384

)

 

$

19.20

 

Outstanding at June 30, 2019

 

 

673,719

 

 

$

18.57

 

 

 

204,261

 

 

$

25.70

 

 

 

1,943,611

 

 

$

21.38

 

Schedule of Activity Related to Stock Option Awards

The activity related to the Company’s stock option awards during the six months ended June 30, 2019 is as follows:

 

 

 

Options

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Life (in years)

 

 

Aggregate

Intrinsic Value       (in thousands)

 

Outstanding at December 31, 2018

 

 

764,577

 

 

$

18.05

 

 

 

 

 

 

 

 

 

Granted

 

 

430,390

 

 

$

25.70

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(92,095

)

 

$

20.97

 

 

 

 

 

 

 

 

 

Expired

 

 

(8,593

)

 

$

18.52

 

 

 

 

 

 

 

 

 

Exercised

 

 

(131,176

)

 

$

17.80

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2019

 

 

963,103

 

 

$

21.22

 

 

 

7.67

 

 

$

9,417

 

Exercisable at June 30, 2019

 

 

464,385

 

 

$

18.38

 

 

 

6.21

 

 

$

5,859

 

Schedule of Stock Options Valuation Assumptions

The weighted average grant date fair value of stock options granted during the six months ended June 30, 2019 was $8.45. Key weighted-average assumptions utilized in the Black-Scholes Option Pricing Model for stock options granted during the six months ended June 30, 2019 were:

Risk-free interest rate

 

 

2.48

%

Expected volatility (a)

 

 

28.50

%

Expected dividend yield

 

 

0.00

%

Expected life (years) (b)

 

 

6.00

 

(a)

Due to the Company’s limited history as a public company, the volatility for the Company’s stock at the date of each grant was estimated using the average volatility calculated for a peer group, which is based upon daily price observations over the estimated term of options granted.

(b)

The expected life was estimated using the simplified method, as the Company does not have sufficient historical exercise data due to the limited period of time its common stock has been publicly traded.